Lung cancer is among most common types of cancers in U.S. as well as around the world. According to the Centers for Disease Control and Prevention, it is responsible for nearly a…
Tag: New Lung Cancer Treatment
Lung Cancer Outcomes May Be Improved By Chemo With TKI Drug
Gefitinib and chemotherapy may be considered a first-line treatment option for patients with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) with brain metastases. Recent research has shown that patients with Epidermal Growth Factor…
FDA Approves Adjuvant Pembrolizumab for Non-Small Cell Lung Cancer Treatment
The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with NSCLC (non-small cell lung cancer). This approval has been based on the…
US FDA Approves Imfinzi and Imjudo with Chemotherapy for Lung Cancer
AstraZeneca’s Imfinzi in combination with Imjudo plus platinum-based chemotherapy has been approved for treatment of patients with Stage IV non-small cell lung cancer (NSCLC). The approval has been made by the Food…
FDA Grants Approval to Trastuzumab Deruxtecan for HER2 Lung Cancer
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab deruxtecan. This drug is already approved for use in HER2-positive breast cancer…
Lung Cancer Treatment Side Effects Prevented with Genetic Discovery
Lung cancer is one of the deadliest forms of cancers prevalent globally. Immunotherapy has emerged as one of the most effective ways to control this disease. But, it causes several side effects…
Plant Compound Berberine May Help Fight Lung Cancer
Lung cancer is the leading cause of cancer related deaths among men and women and the scientific community continues to make efforts to find new ways for lung cancer treatment. In a…
FDA Approves FoundationOne CDx in Non-Small Cell Lung Cancer
U.S. Food and Drug Administration (FDA) has approved the FoundationOne CDx as a companion diagnostic to guide treatment selection for patients with non-small cell lung cancer. This approval applies to the use…